Marc H. Glickman's most recent trade in enVVeno Medical Corporation was a trade of 75,000 Stock Options done . Disclosure was reported to the exchange on Dec. 18, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| enVVeno Medical Corporation | Marc H. Glickman | SVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2024 | 75,000 | 75,000 | - | - | Stock Options | |
| enVVeno Medical Corporation | Marc Glickman H. | SVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2023 | 100,000 | 100,000 | - | - | Stock Options | |
| enVVeno Medical Corporation | Marc H. Glickman | SVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 265,700 | 265,700 | - | - | Stock Options | |
| enVVeno Medical Corporation | Marc H. Glickman | SVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 100,000 | 101,600 (0%) | 0% | - | Common Stock | |
| enVVeno Medical Corporation | Marc H. Glickman | SVP & Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 5.90 per share. | 21 May 2021 | 1,600 | 1,600 (0%) | 0% | 5.9 | 9,440 | Common Stock |
| enVVeno Medical Corporation | Marc H. Glickman | SVP & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 406,000 | 406,000 | - | - | Stock Option |